Nitzan Arad is a Research Associate at the Duke-Margolis Center for Health Policy. Her work focuses on drug pricing and payment reforms in Medicare and Medicaid, the legal barriers to value-based payment arrangements for medical products and population-based payment models.
Before joining Duke-Margolis, she was a Director of Public Policy at Teva Pharmaceuticals, where she led research and analysis on a variety of government pricing and reimbursement, intellectual property, trade policy and biosimilar issues, in the U.S. and in international markets. She also interacted regularly with different industry associations and developed policy strategies to support company advocacy efforts on various topics.
Health policy research and analysis, pharmaceuticals, drug payment reform, project management, stakeholder engagement.
Nitzan holds an LL.B. in Law from the Hebrew University of Jerusalem and an LL.M. degree from the Duke University School of Law. She is admitted to practice in the State of New York.